12182374

Source:http://linkedlifedata.com/resource/pubmed/id/12182374

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006823, umls-concept:C0035236, umls-concept:C0042153, umls-concept:C0672596, umls-concept:C1274040, umls-concept:C1708528
pubmed:issue	6
pubmed:dateCreated	2002-8-16
pubmed:abstractText	To provide information on the use and outcomes of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus (RSV) infection.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8701858
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/palivizumab
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0891-3668
pubmed:author	pubmed-author:Composs Investigators, pubmed-author:Lanct?tKrista LKL, pubmed-author:LeeDavid S CDS, pubmed-author:ManziPatriciaP, pubmed-author:OhPaul IPI, pubmed-author:PaesBosco ABA, pubmed-author:ParisonDianaD, pubmed-author:SimmonsBrian SBS, pubmed-author:YoonAliceA
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	512-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:12182374-Antibodies, Monoclonal, pubmed-meshheading:12182374-Antibodies, Monoclonal, Humanized, pubmed-meshheading:12182374-Antiviral Agents, pubmed-meshheading:12182374-Bronchopulmonary Dysplasia, pubmed-meshheading:12182374-Canada, pubmed-meshheading:12182374-Demography, pubmed-meshheading:12182374-Female, pubmed-meshheading:12182374-Guideline Adherence, pubmed-meshheading:12182374-Hospitalization, pubmed-meshheading:12182374-Humans, pubmed-meshheading:12182374-Infant, Newborn, pubmed-meshheading:12182374-Infant, Premature, pubmed-meshheading:12182374-Longitudinal Studies, pubmed-meshheading:12182374-Male, pubmed-meshheading:12182374-Respiratory Syncytial Virus Infections, pubmed-meshheading:12182374-Respiratory Syncytial Viruses, pubmed-meshheading:12182374-Risk Factors, pubmed-meshheading:12182374-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.
pubmed:affiliation	HOPE Research Centre, Sunnybrook, and Women's College Health Sciences Centre, University of Toronto, Ontario, Canada. paul.oh@swchsc.on.ca
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study